Scientists find natural compounds that hit COVID-19 from every angle - ScienceDaily

Scientists find natural compounds that hit COVID-19 from every angle  ScienceDaily

After Exposure, Then What? Closing the COVID-19 Prevention Gap - EMJ

After Exposure, Then What? Closing the COVID-19 Prevention Gap  EMJ

Retrospective Drug Utilization Pattern of the Use of Antivirals and Its Outcome in Hospitalized C...

Retrospective Drug Utilization Pattern of the Use of Antivirals and Its Outcome in Hospitalized COVID-19 Patients in a Tertiary Care Hospital in Mumbai From July to October 2020  Cureus

Scientists find that human embryos are vulnerable to COVID - News-Medical

Scientists find that human embryos are vulnerable to COVID  News-Medical

Coronavirus disease (COVID-19) - World Health Organization (WHO)

Coronavirus disease (COVID-19)  World Health Organization (WHO)

What COVID-19 can still teach us about preparing for the next epidemic - UNC Gillings School of G...

What COVID-19 can still teach us about preparing for the next epidemic  UNC Gillings School of Global Public Health

Video How contagious is hantavirus and is it similar to the SARS-CoV-2 virus? - ABC News - Breaki...

Video How contagious is hantavirus and is it similar to the SARS-CoV-2 virus?  ABC News - Breaking News, Latest News and Videos

Types of COVID-19 Treatment - Centers for Disease Control and Prevention | CDC (.gov)

Types of COVID-19 Treatment  Centers for Disease Control and Prevention | CDC (.gov)

Presence of SARS-CoV-2 in fetal organs via intraamniotic infection - Nature

Presence of SARS-CoV-2 in fetal organs via intraamniotic infection  Nature

Recent pandemic viruses, including SAR-CoV-2, spread directly to people without adaptation, resea...

Recent pandemic viruses, including SAR-CoV-2, spread directly to people without adaptation, researchers say  CIDRAP

COVID-19's lingering shadow: The molecular link between SARS-CoV-2 and lung cancer risk - Medical...

COVID-19's lingering shadow: The molecular link between SARS-CoV-2 and lung cancer risk  Medical Xpress

Long COVID associated with SARS-CoV-2 reinfection among children and adolescents in the omicron e...

Long COVID associated with SARS-CoV-2 reinfection among children and adolescents in the omicron era (RECOVER-EHR): a retrospective cohort study  The Lancet

“This is Not SARS-CoV-2”: WHO Quashes Hantavirus Pandemic Fears - EMJ

“This is Not SARS-CoV-2”: WHO Quashes Hantavirus Pandemic Fears  EMJ

National Wastewater Data for Respiratory Viruses - Centers for Disease Control and Prevention | C...

National Wastewater Data for Respiratory Viruses  Centers for Disease Control and Prevention | CDC (.gov)

Gut infection and dysbiosis are hallmarks of severe SARS-CoV-2 variants - Nature

Gut infection and dysbiosis are hallmarks of severe SARS-CoV-2 variants  Nature

New COVID variant with immune escape potential confirmed in US, 22 other countries - CIDRAP

New COVID variant with immune escape potential confirmed in US, 22 other countries  CIDRAP

Middle East respiratory syndrome coronavirus (MERS-CoV) - World Health Organization (WHO)

Middle East respiratory syndrome coronavirus (MERS-CoV)  World Health Organization (WHO)

Paternal SARS-CoV-2 infection impacts sperm small noncoding RNAs and increases anxiety in offspri...

Paternal SARS-CoV-2 infection impacts sperm small noncoding RNAs and increases anxiety in offspring in a sex-dependent manner  Nature

COVID-19 Treatment Clinical Care for Outpatients - Centers for Disease Control and Prevention | C...

COVID-19 Treatment Clinical Care for Outpatients  Centers for Disease Control and Prevention | CDC (.gov)

A SARS-CoV-2 variant‑adjusted threshold of protection model for monoclonal antibody pre-exposure ...

A SARS-CoV-2 variant‑adjusted threshold of protection model for monoclonal antibody pre-exposure prophylaxis against COVID-19  Nature

SARS-CoV-2 within-host population expansion, diversification and adaptation in zoo tigers, lions ...

SARS-CoV-2 within-host population expansion, diversification and adaptation in zoo tigers, lions and hyenas  Nature

Does ultraviolet (UV) light kill the coronavirus? - National Academies of Sciences, Engineering, ...

Does ultraviolet (UV) light kill the coronavirus?  National Academies of Sciences, Engineering, and Medicine

SARS-CoV-2 variants: biology, pathogenicity, immunity and control - Nature

SARS-CoV-2 variants: biology, pathogenicity, immunity and control  Nature

Statement on the antigen composition of COVID-19 vaccines - World Health Organization (WHO)

Statement on the antigen composition of COVID-19 vaccines  World Health Organization (WHO)

The mutational landscape of SARS-CoV-2 provides new insight into viral evolution and fitness - Na...

The mutational landscape of SARS-CoV-2 provides new insight into viral evolution and fitness  Nature

Understanding the COVID-19 Cicada Variant (BA.3.2): Symptoms, Spread and Protection - Stony Brook...

Understanding the COVID-19 Cicada Variant (BA.3.2): Symptoms, Spread and Protection  Stony Brook Medicine

Molecular basis of SARS-CoV-2 proofreading enzyme–mediated resistance to remdesivir - PNAS

Molecular basis of SARS-CoV-2 proofreading enzyme–mediated resistance to remdesivir  PNAS

COVID-19: how worried should we be about the Frankenstein variant? | - Institut Pasteur

COVID-19: how worried should we be about the Frankenstein variant? |  Institut Pasteur

The Virtual Lab of AI agents designs new SARS-CoV-2 nanobodies - Nature

The Virtual Lab of AI agents designs new SARS-CoV-2 nanobodies  Nature

WHO Scientific advisory group issues report on origins of COVID-19 - World Health Organization (WHO)

WHO Scientific advisory group issues report on origins of COVID-19  World Health Organization (WHO)

SARS-CoV-2 Causes Buildup of Alzheimer’s-Related Peptides in the Retina - Yale School of Medicine

SARS-CoV-2 Causes Buildup of Alzheimer’s-Related Peptides in the Retina  Yale School of Medicine

Current status and future perspectives on the mechanistic and pathophysiological understanding of...

Current status and future perspectives on the mechanistic and pathophysiological understanding of long COVID  Nature

COVID-19 and Breastfeeding - Centers for Disease Control and Prevention | CDC (.gov)

COVID-19 and Breastfeeding  Centers for Disease Control and Prevention | CDC (.gov)

Ultrapotent SARS coronavirus-neutralizing single-domain antibodies that clamp the spike at its ba...

Ultrapotent SARS coronavirus-neutralizing single-domain antibodies that clamp the spike at its base  Nature

SARS-CoV-2 nucleocapsid protein directly prevents cGAS–DNA recognition through competitive bindin...

SARS-CoV-2 nucleocapsid protein directly prevents cGAS–DNA recognition through competitive binding  PNAS

SARS-CoV-2 induced immune perturbations in infants vary with disease severity and differ from adu...

SARS-CoV-2 induced immune perturbations in infants vary with disease severity and differ from adults’ responses  Nature

Study Shows SARS-CoV-2 Corrupts Some White Blood Cells to Suppress Immune System, Suggesting a Pa...

Study Shows SARS-CoV-2 Corrupts Some White Blood Cells to Suppress Immune System, Suggesting a Path to Severe COVID  Johns Hopkins Medicine

New coronavirus found in Thailand may be able to infect people: study - Nikkei Asia

New coronavirus found in Thailand may be able to infect people: study  Nikkei Asia

National flu and COVID-19 surveillance report: 30 April 2026 (week 18) - GOV.UK

National flu and COVID-19 surveillance report: 30 April 2026 (week 18)  GOV.UK

SARD Patients May Exhibit Higher and Prolonged Persistence of COVID-19 Viral Antigens: Study - Me...

SARD Patients May Exhibit Higher and Prolonged Persistence of COVID-19 Viral Antigens: Study  Medical Dialogues

Postacute Sequelae of SARS-CoV-2 Infection in the Pre-Delta, Delta, and Omicron Eras - The New En...

Postacute Sequelae of SARS-CoV-2 Infection in the Pre-Delta, Delta, and Omicron Eras  The New England Journal of Medicine

SARS-CoV-2 fragments may cause problems after infection - National Institutes of Health (.gov)

SARS-CoV-2 fragments may cause problems after infection  National Institutes of Health (.gov)

Tracking SARS-CoV-2 variants - World Health Organization (WHO)

Tracking SARS-CoV-2 variants  World Health Organization (WHO)

SARS-CoV-2 and COVID-19 - Baylor College of Medicine | BCM

SARS-CoV-2 and COVID-19  Baylor College of Medicine | BCM

Electromagnetic waves destabilize the SARS-CoV-2 Spike protein and reduce SARS-CoV-2 Virus-Like p...

Electromagnetic waves destabilize the SARS-CoV-2 Spike protein and reduce SARS-CoV-2 Virus-Like particle (SC2-VLP) infectivity | Scientific Reports  Nature

Coronavirus disease (COVID-19) - World Health Organization (WHO)

Coronavirus disease (COVID-19)  World Health Organization (WHO)

Pre–Covid-19, SARS-CoV-2–Negative Multisystem Inflammatory Syndrome in Children - The New England...

Pre–Covid-19, SARS-CoV-2–Negative Multisystem Inflammatory Syndrome in Children  The New England Journal of Medicine

Long COVID after SARS-CoV-2 during pregnancy in the United States - Nature

Long COVID after SARS-CoV-2 during pregnancy in the United States  Nature

Transmission of SARS-CoV-2: implications for infection prevention precautions - World Health Orga...

Transmission of SARS-CoV-2: implications for infection prevention precautions  World Health Organization (WHO)

Human SARS-CoV-2 challenge uncovers local and systemic response dynamics - Nature

Human SARS-CoV-2 challenge uncovers local and systemic response dynamics  Nature

Phenotypic evolution of SARS-CoV-2 spike during the COVID-19 pandemic - Nature

Phenotypic evolution of SARS-CoV-2 spike during the COVID-19 pandemic  Nature

COVID-19 tissue atlases reveal SARS-CoV-2 pathology and cellular targets - Nature

COVID-19 tissue atlases reveal SARS-CoV-2 pathology and cellular targets  Nature

SARS-CoV-2 restructures host chromatin architecture - Nature

SARS-CoV-2 restructures host chromatin architecture  Nature

Outbreak of SARS-CoV-2 Infections, including COVID-19 ... - Centers for Disease Control and Preve...

Outbreak of SARS-CoV-2 Infections, including COVID-19 ...  Centers for Disease Control and Prevention | CDC (.gov)

Widespread exposure to SARS-CoV-2 in wildlife communities - Nature

Widespread exposure to SARS-CoV-2 in wildlife communities  Nature

SARS-CoV-2 infection and persistence in the human body and brain at autopsy - Nature

SARS-CoV-2 infection and persistence in the human body and brain at autopsy  Nature

The persistence of SARS-CoV-2 in tissues and its association with long COVID symptoms: a cross-se...

The persistence of SARS-CoV-2 in tissues and its association with long COVID symptoms: a cross-sectional cohort study in China  The Lancet

Plasma proteomic evidence for increased β-amyloid pathology after SARS-CoV-2 infection - Nature

Plasma proteomic evidence for increased β-amyloid pathology after SARS-CoV-2 infection  Nature

Severe Acute Respiratory Syndrome (SARS) - World Health Organization (WHO)

Severe Acute Respiratory Syndrome (SARS)  World Health Organization (WHO)

SARS-CoV-2 pathogenesis - Nature

SARS-CoV-2 pathogenesis  Nature

SARS-CoV-2 infection triggers pro-atherogenic inflammatory responses in human coronary vessels - ...

SARS-CoV-2 infection triggers pro-atherogenic inflammatory responses in human coronary vessels  Nature

Animals and COVID-19 - Centers for Disease Control and Prevention | CDC (.gov)

Animals and COVID-19  Centers for Disease Control and Prevention | CDC (.gov)

SARS-CoV-2 Variants in Patients with Immunosuppression - The New England Journal of Medicine

SARS-CoV-2 Variants in Patients with Immunosuppression  The New England Journal of Medicine

The proximal origin of SARS-CoV-2 - Nature

The proximal origin of SARS-CoV-2  Nature

Protection against SARS-CoV-2 after Covid-19 Vaccination and Previous Infection - The New England...

Protection against SARS-CoV-2 after Covid-19 Vaccination and Previous Infection  The New England Journal of Medicine

The species Severe acute respiratory syndrome-related coronavirus : classifying 2019-nCoV and nam...

The species Severe acute respiratory syndrome-related coronavirus : classifying 2019-nCoV and naming it SARS-CoV-2  Nature

Emergence of a Highly Fit SARS-CoV-2 Variant - The New England Journal of Medicine

Emergence of a Highly Fit SARS-CoV-2 Variant  The New England Journal of Medicine

SARS-CoV-2 antigenemia and RNAemia in association with disease severity in patients with COVID-19...

SARS-CoV-2 antigenemia and RNAemia in association with disease severity in patients with COVID-19  Nature

Laboratory-Confirmed COVID-19 Among Adults Hospitalized ... - Centers for Disease Control and Pre...

Laboratory-Confirmed COVID-19 Among Adults Hospitalized ...  Centers for Disease Control and Prevention | CDC (.gov)

SARS-CoV-2 Variant XEC Increases as KP.3.1.1 Slows - Centers for Disease Control and Prevention |...

SARS-CoV-2 Variant XEC Increases as KP.3.1.1 Slows  Centers for Disease Control and Prevention | CDC (.gov)

Long COVID after breakthrough SARS-CoV-2 infection - Nature

Long COVID after breakthrough SARS-CoV-2 infection  Nature

SARS-CoV-2-reactive T cells in healthy donors and patients with COVID-19 - Nature

SARS-CoV-2-reactive T cells in healthy donors and patients with COVID-19  Nature

How SARS-CoV-2 Evolved Through the COVID Pandemic - WCM Newsroom

How SARS-CoV-2 Evolved Through the COVID Pandemic  WCM Newsroom

Mechanisms of SARS-CoV-2 entry into cells - Nature

Mechanisms of SARS-CoV-2 entry into cells  Nature

Aerosol and Surface Stability of SARS-CoV-2 as Compared with SARS-CoV-1 - The New England Journal...

Aerosol and Surface Stability of SARS-CoV-2 as Compared with SARS-CoV-1  The New England Journal of Medicine

Metabolic alterations upon SARS-CoV-2 infection and potential therapeutic targets against coronav...

Metabolic alterations upon SARS-CoV-2 infection and potential therapeutic targets against coronavirus infection  Nature

First Reported Cases of SARS-CoV-2 Infection in Companion Animals — New York, March–April 2020 | ...

First Reported Cases of SARS-CoV-2 Infection in Companion Animals — New York, March–April 2020 | MMWR  Centers for Disease Control and Prevention | CDC (.gov)

Reduced Risk of Reinfection with SARS-CoV-2 After COVID-19 Vaccination — Kentucky, May–June 2021 ...

Reduced Risk of Reinfection with SARS-CoV-2 After COVID-19 Vaccination — Kentucky, May–June 2021 | MMWR  Centers for Disease Control and Prevention | CDC (.gov)

Tracking the evolution of anti-SARS-CoV-2 antibodies and long-term humoral immunity within 2 year...

Tracking the evolution of anti-SARS-CoV-2 antibodies and long-term humoral immunity within 2 years after COVID-19 infection  Nature

Sensing of SARS-CoV-2 by pDCs and their subsequent production of IFN-I contribute to macrophage-i...

Sensing of SARS-CoV-2 by pDCs and their subsequent production of IFN-I contribute to macrophage-induced cytokine storm during COVID-19  Science | AAAS

Structural and functional properties of SARS-CoV-2 spike protein: potential antivirus drug develo...

Structural and functional properties of SARS-CoV-2 spike protein: potential antivirus drug development for COVID-19  Nature

SARS-CoV-2 can cause lasting damage to cells' energy production - National Institutes of Health (...

SARS-CoV-2 can cause lasting damage to cells' energy production  National Institutes of Health (.gov)

Prevalence of persistent SARS-CoV-2 in a large community surveillance study - Nature

Prevalence of persistent SARS-CoV-2 in a large community surveillance study  Nature

SARS-CoV-2 Variants and Vaccines - The New England Journal of Medicine

SARS-CoV-2 Variants and Vaccines  The New England Journal of Medicine

How does SARS-CoV-2 cause COVID-19? - Science | AAAS

How does SARS-CoV-2 cause COVID-19?  Science | AAAS

Risk of BA.5 Infection among Persons Exposed to Previous SARS-CoV-2 Variants - The New England Jo...

Risk of BA.5 Infection among Persons Exposed to Previous SARS-CoV-2 Variants  The New England Journal of Medicine

Coronavirus biology and replication: implications for SARS-CoV-2 - Nature

Coronavirus biology and replication: implications for SARS-CoV-2  Nature

Characteristics of SARS-CoV-2 and COVID-19 - Nature

Characteristics of SARS-CoV-2 and COVID-19  Nature

Impact of SARS-CoV-2 infection on respiratory and gut microbiome stability: a metagenomic investi...

Impact of SARS-CoV-2 infection on respiratory and gut microbiome stability: a metagenomic investigation in long-term-hospitalized COVID-19 patients  Nature

Transmission of SARS-CoV-2 in free-ranging white-tailed deer in the United States - Nature

Transmission of SARS-CoV-2 in free-ranging white-tailed deer in the United States  Nature

SARS-CoV-2 Neutralizing Antibody LY-CoV555 in Outpatients with Covid-19 - The New England Journal...

SARS-CoV-2 Neutralizing Antibody LY-CoV555 in Outpatients with Covid-19  The New England Journal of Medicine

Statement on the antigen composition of COVID-19 vaccines - World Health Organization (WHO)

Statement on the antigen composition of COVID-19 vaccines  World Health Organization (WHO)

SARS-CoV-2 reservoir in post-acute sequelae of COVID-19 (PASC) - Nature

SARS-CoV-2 reservoir in post-acute sequelae of COVID-19 (PASC)  Nature

SARS-CoV-2-specific T cell immunity in cases of COVID-19 and SARS, and uninfected controls - Nature

SARS-CoV-2-specific T cell immunity in cases of COVID-19 and SARS, and uninfected controls  Nature

Detection of Covid-19 Outbreaks Using Built Environment Testing for SARS-CoV-2 - NEJM Evidence

Detection of Covid-19 Outbreaks Using Built Environment Testing for SARS-CoV-2  NEJM Evidence

Immunology of SARS-CoV-2 infection in children - Nature

Immunology of SARS-CoV-2 infection in children  Nature

COVID-19 (SARS-CoV-2 virus) - Institut Pasteur

COVID-19 (SARS-CoV-2 virus)  Institut Pasteur

Safety, tolerability and viral kinetics during SARS-CoV-2 human challenge in young adults - Nature

Safety, tolerability and viral kinetics during SARS-CoV-2 human challenge in young adults  Nature

Microfluidic particle dam for direct visualization of SARS-CoV-2 antibody levels in COVID-19 vacc...

Microfluidic particle dam for direct visualization of SARS-CoV-2 antibody levels in COVID-19 vaccinees  Science | AAAS

Ultrasensitive detection of intact SARS-CoV-2 particles in complex biofluids using microfluidic a...

Ultrasensitive detection of intact SARS-CoV-2 particles in complex biofluids using microfluidic affinity capture  Science | AAAS